what is the medication error for PO Mefenamic acid [ponstan] 500mg TDS ?
Generice Name: Mefenamic Acid Brand Name:Ponstan, Ponstel Classifications:central nervous system agent; analgesic; nsaid; antipyretic Pregnancy Category:C Availability 250 mg tablets Actions Anthranilic acid derivative. Like ibuprofen inhibits prostaglandin synthesis and affects platelet function. No evidence that it is superior to aspirin. Therapeutic effects Analgesic, antiinflammatory, and antipyretic actions similar to those of ibuprofen. Uses Short-term relief of mild to moderate pain including primary dysmenorrhea. Contraindications Hypersensitivity to drug;GI inflammation,or ulceration.Safety in children <14 y, during pregnancy (category C), or lactation is not established. Cautious use History of kidney or liver disease;blood dyscrasias;asthma;diabetes mellitus;hypersensitivity to aspirin. Long term use increases risk of serious adverse events. Route & Dosage Mild to Moderate Pain adult: PO Loading Dose 500 mg PO Maintenance Dose 250 mg q6h prn Administration Oral Give with meals, food, or milk to minimize GI adverse effects. Do not use drug for a period exceeding 1 wk (manufacturer’s warning). Adverse effects CNS:Drowsiness, insomnia, dizziness, nervousness, confusion, headache. GI:Severe diarrhea, ulceration, and bleeding; nausea, vomiting, abdominal cramps, flatus, constipation, hepatic toxicity. Hematologic:Prolonged prothrombin time, severe autoimmune hemolytic anemia (long-term use), leukopenia, eosinophilia, agranulocytosis, thrombocytopenic purpura, megaloblastic anemia, pancytopenia, bone marrow hypoplasia. Urogenital:Nephrotoxicity, dysuria, albuminuria, hematuria, elevation of BUN. Skin:Urticaria, rash, facial edema. SpecSenses:Eye irritation, loss of color vision (reversible), blurred vision, ear pain. BodyWhole:Perspiration. CV:Palpitation. Respiratory:Dyspnea; acute exacerbation of asthma; bronchoconstriction (in patients sensitive to aspirin). - See more at: http://rnspeak.com/drug-study/mefenamic-acid-ponstan-drug-study/#sthash.lTedUUKj.dpuf
Join our real-time social learning platform and learn together with your friends!